David A Parker, Rebekah L Trotti, Jennifer E McDowell, Sarah K Keedy, Matcheri S Keshavan, Godfrey D Pearlson, Elliot S Gershon, Elena I Ivleva, Ling-Yu Huang, Kodiak Sauer, S Kristian Hill, John A Sweeney, Carol A Tamminga, Brett A Clementz
{"title":"Differentiating biomarker features and familial characteristics of B-SNIP psychosis Biotypes.","authors":"David A Parker, Rebekah L Trotti, Jennifer E McDowell, Sarah K Keedy, Matcheri S Keshavan, Godfrey D Pearlson, Elliot S Gershon, Elena I Ivleva, Ling-Yu Huang, Kodiak Sauer, S Kristian Hill, John A Sweeney, Carol A Tamminga, Brett A Clementz","doi":"10.1038/s41398-025-03501-5","DOIUrl":null,"url":null,"abstract":"<p><p>Idiopathic psychosis shows considerable biological heterogeneity across cases. The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) used psychosis-relevant biomarkers to identify psychosis Biotypes, which will aid etiological and targeted treatment investigations. Here, our previous approach (Clementz et al. 2022) is updated, which supports the development of an efficient psychosis Biotype diagnostic procedure called ADEPT. Psychosis probands (n = 1907), their first-degree biological relatives (n = 705), and healthy participants (n = 895) completed a biomarker battery composed of cognitive performance, saccades, and auditory EEG/ERP measurements. EEG and ERP quantifications were modified from previous Biotypes iterations. Multivariate integration using multiple approaches reduced biomarker outcomes to 11 \"bio-factors.\" Twenty-four different approaches indicated bio-factor data among probands were best described by three subgroups. Numerical taxonomy with k-means clustering yielded psychosis Biotypes; Rand Indices evaluated individual-case consistency of Biotype assignments. Psychosis subgroups, their non-psychotic first-degree relatives, and healthy individuals were compared across bio-factors. The three psychosis Biotypes differed significantly on all 11 bio-factors, especially prominent for general cognition, antisaccades, ERP magnitude, and intrinsic neural activity. Rand Indices showed excellent individual-case consistency of Biotype membership when samples included more than 1000 subjects. Canonical discriminant analysis described composite bio-factors that simplified group comparisons: \"Pattern-2\" (high antisaccade errors, low BACS, high ongoing EEG) captured Biotype-2, \"Pattern-1\" (low ERP amplitudes, low intrinsic EEG) captured Biotype-1, and \"Pattern-3\" (low frontal P3 complex, accentuated S2 ERP, faster saccadic reaction times) captured Biotype-3. First-degree relatives had patterns like their proband for general cognition, antisaccades, ERP magnitudes, and intrinsic brain activity. These outcomes refine and extend operations for characterizing biologically distinct psychosis Biotypes. They also show that over 1000 observations are useful for achieving consistent individual-case diagnostic assignments. First-degree relative data implicate specific bio-factors as familial within idiopathic psychosis which may inform genetic studies.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"281"},"PeriodicalIF":6.2000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12354876/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03501-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Idiopathic psychosis shows considerable biological heterogeneity across cases. The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) used psychosis-relevant biomarkers to identify psychosis Biotypes, which will aid etiological and targeted treatment investigations. Here, our previous approach (Clementz et al. 2022) is updated, which supports the development of an efficient psychosis Biotype diagnostic procedure called ADEPT. Psychosis probands (n = 1907), their first-degree biological relatives (n = 705), and healthy participants (n = 895) completed a biomarker battery composed of cognitive performance, saccades, and auditory EEG/ERP measurements. EEG and ERP quantifications were modified from previous Biotypes iterations. Multivariate integration using multiple approaches reduced biomarker outcomes to 11 "bio-factors." Twenty-four different approaches indicated bio-factor data among probands were best described by three subgroups. Numerical taxonomy with k-means clustering yielded psychosis Biotypes; Rand Indices evaluated individual-case consistency of Biotype assignments. Psychosis subgroups, their non-psychotic first-degree relatives, and healthy individuals were compared across bio-factors. The three psychosis Biotypes differed significantly on all 11 bio-factors, especially prominent for general cognition, antisaccades, ERP magnitude, and intrinsic neural activity. Rand Indices showed excellent individual-case consistency of Biotype membership when samples included more than 1000 subjects. Canonical discriminant analysis described composite bio-factors that simplified group comparisons: "Pattern-2" (high antisaccade errors, low BACS, high ongoing EEG) captured Biotype-2, "Pattern-1" (low ERP amplitudes, low intrinsic EEG) captured Biotype-1, and "Pattern-3" (low frontal P3 complex, accentuated S2 ERP, faster saccadic reaction times) captured Biotype-3. First-degree relatives had patterns like their proband for general cognition, antisaccades, ERP magnitudes, and intrinsic brain activity. These outcomes refine and extend operations for characterizing biologically distinct psychosis Biotypes. They also show that over 1000 observations are useful for achieving consistent individual-case diagnostic assignments. First-degree relative data implicate specific bio-factors as familial within idiopathic psychosis which may inform genetic studies.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.